Bridging The Data Divide: Standardization And Interoperability In Natural Product Databases & Artificial Intelligence In Drug Discovery

2.1 FAIR Principles in Pharmacognosy

Findable, Accessible, Interoperable, Reusable - these are the data principles mandated for modern informatics [4]. The Natural Products Atlas [4] stands as a prime example of a FAIR-aligned architecture in microbial pharmacognosy. Through strict peer-reviewed isolation citation requirements, data validation of skeletal structures and assignments, and persistent unique chemical identifiers (NPAtlas IDs), data fidelity is high. Yet microbial metabolites account for only a fraction of the total therapeutic space in nature. Phytochemicals derived from plants (e.g., complex alkaloids, polyphenols, triterpenoid saponins) remain fragmented and dispersed within heterogeneous databases (e.g., TCMSP, IMPPAT, KNApSAcK), many of which lack standardized structural validation protocols or continuous programmatic API accessibility [1, 5].

2.2 Large-Scale Aggregators: SuperNatural 3.0 and COCONUT

To close the niche gap, efforts like SuperNatural 3.0 [5] and the Collection of Open Natural Products (COCONUT) have aggregated hundreds of thousands of structures. SuperNatural 3.0 cross-references the chemical structure of compounds with predicted toxicity profiles, biological pathways, and vendor availability. But large aggregators present a dire paradox of their own: when legacy data is ingested from an uncurated primary literature source, introduced errors in the original published article (incorrect double-bond geometries, missing stereocenter uncertainties, and glycosidic linkage misassignments) are systematically copied and reinforced through the entire computational ecosystem [5].

3. The Standardization Crisis in AI-Driven Pharmacogonosy

The use of machine learning algorithms in drug discovery involves the translation of 3D chemical structures into machine-processible mathematical representations (binary molecular fingerprints, molecular graphs, or 1D string notations). When chemical data is unstandardized in this process, AI models “learn” erroneous patterns that greatly degrade predictive performance.

3.1 Stereochemical Loss and Chiral Ambiguity

Secondary metabolites are inherently chiral compounds. The specific spatial orientation of the molecule across the chiral centers defines their thermodynamic binding affinity at protein receptors. The enantiomers of carvedilol and limonin, for instance, exhibit drastically different therapeutic properties. Yet legacy data conversion pipelines often flatten 3D structures into non-stereospecific 2D representations. Exported as standard Simplified Molecular-Input Line-Entry System (SMILES) strings without explicit chiral flags (R/S or @/@@ identifiers), all stereoisomers are collapsed into one topological chemical entity [4, 5].

3.2 Tautomerism, Protonation States, and Salts

Phytochemicals such flavonoids and alkaloids exhibit dynamic tautomerization and pH-dependent protonation processes. A database recording a molecule in its neutral (unprotonated) state while another records a protonated salt will cause machine learning models to treat them as completely separate chemical entities, artificially inflating the size of the dataset and distorting feature extraction algorithms [2].

3.3 String Representation Vulnerabilities: SMILES vs. SELFIES

Molecular language models (i.e., GPT-based transformer or Variational Autoencoders) encode chemical structures as sequential string language. The standard SMILES notation operates on a strict format of ring closure and valence constraints. When generative models learn to generate novel NP-like structure using SMILES, over 30-50% of the output strings are syntactically invalid (unclosed rings or pentavalent carbon atoms) [3]. To resolve this limitation, the cheminformatics community created a solution known as SELFIES (Self-Referencing Embedded Strings). SELFIES provides 100% mathematical guarantees by translating strings into localized structural rules. The SELFIES translation from legacy SMILES is now a primary prerequisite for scaling generatively NP discovery pipelines [3].

4. Real-World Case Studies: AI Failures & Solutions

To clearly demonstrate the necessity of standardization in a practical context, we will present two seminal case studies showing how cheminformatics corrections directly influence AI performance in natural product discovery.

Case Study 1: The Stereochemistry Bottleneck & NPstereo Language Model

Context: Machine learning models trained on flat, non-curated natural product databases often fail to predict accurate ligand binding affinities, as traditional published literature typically lacks explicit stereochemical flags (R/S configuration).

Problem: When predicting a multi-stereocenter diterpene or alkaloid, the flat SMILES representation obligates the neural network to infer 3D conformations, leading to severe false positives in virtual screening.

Solution & Impact: Researchers created an open source tool called NPstereo, a transformer-based language model trained exclusively on the open-access COCONUT database. NPstereo functions as an automated post-hoc standardization algorithm. Based on local chemical contexts, NPstereo predicts and flags missing chiral annotations at an >80% accuracy rate across key metabolite classes (alkaloids, terpenoids, and steroids). This case study demonstrates that AI must first be applied to clean and standardize historical data before it can be used to discover novel drug leads with consistency.

Case Study 2: Syntactic Hallucinations in 67 Million Generative NP-Like Compounds

Context: Generative molecular language models were utilized by Tay et al. (2023) [3] to construct an immense virtual database of 67 million natural product-like molecules, expanding the searchable chemical space beyond what is known to exist in Nature.

Problem: In initial training with standard canonical SMILES as input, the model produced a high percentage of syntactically invalid output, ‘hallucinating’ chemically impossible architectures (e.g., hypervalent oxygen atoms, broken aromaticity, and invalid stereocenters).

Solution & Impact: By translating the underlying structure pipeline to robust, cheminformatics-validated representations (including SELFIES and strict valence-checked InChIKeys), the research group removed syntactically erroneous compounds. This enabled deep learning models to efficiently screen the 67 million virtual compounds and identify novel bio-inspired lead compounds targeting multi-drug resistant bacterial pathogens.

Standardized 5-Part Botanical & Phytochemical Analysis Framework

To create AI databases that capture the complete biological and chemical detail of medicinal botanicals, future database architectures must standardize data ingestion across five necessary pharmacognostical components. Below is the standardized framework required for digital monograph integration:

5.1 Botanical & Ethnopharmacological Profile

Taxonomical integrity is paramount. Databases must combine validated Latin binomials from World Flora Online (WFO) with family designation, geographical site (latitude/longitude coordinates), and structured ethnobotanical keywords (Traditional Ayurvedic, TCM, Unani uses, etc.).

5.2 Phytochemical Composition & Chemical Classes

Molecules must be classified into hierarchically secondary metabolite (e.g., monoterpenoid indole alkaloids, prenylated flavonoids, proanthocyanidins) categories with standardized Chemical Entities of Biological Interest (ChEBI) ontology terms.

5.3 Extraction, Isolation & Processing Metadata

AI models anticipating compound yield or bioactivity potential must encode extraction metadata: solvent polarity (i.e., supercritical CO2, ethanol, water), extraction technique (i.e., Soxhlet, ultrasound-assisted extraction), and chromatographic separation methods (HPLC-PDA and LC-MS/MS).

5.4 Pharmacological Activity & Molecular Target Mechanisms

Bioactivity records must be more than qualitative description (i.e., ‘anti-inflammatory’) and include quantitative, structured endpoint parameters such as IC50, EC50, Ki, protein target UniProt ID, and biological signal transduction pathways affected (e.g., NF-kB inhibition, MAPK phosphorylation).

5.5 Standardization, Biomarkers & Quality Control

Monographs must include quantified reference biomarkers (e.g., curcuminoids in Curcuma longa; sennosides in Cassia angustifolia), potential adulterants, heavy metal contamination limits and standardized analytical HPTLC/HPLC fingerprint profiles.

DISCUSSION & FUTURE ROADMAP FOR AI HARMONIZATION

To unlock the full potential of artificial intelligence in natural product drug discovery, an urgent paradigm shift in how phytochemical data is curated, published, and shared across the academic and industry research community is required. No amount of algorithmic intelligence can compensate for fundamentally flawed input data. We suggest a three-tiered roadmap for global natural product database harmonization:

Journal & Publisher Mandatory Reporting Standards: Academic research journals accepting novel isolation or pharmacognostical research papers must mandatorily require submission of fully validated chemical structure data files (FAIR compliant SDF or SELFIES) with confirmed 3D stereochemistry, raw mass spectra data (MS/MS), and NMR FID files in addition to classical manuscript text [1, 4].

Automated ML Data Cleaning Pipelines: Implementation of open-source cheminformatics validation pipelines (i.e., RDKit, Open Babel, CDK) that automate salt removal, tautomerization, protonation state assignment at physiological (pH 7.4), and flagging of ambiguous chiral centers upon data entry [5].

Integration of Multi-Omics and Ethnopharmacology: Linking standardized chemical structures with genomic biosynthetic gene cluster (BGC) data from antiSMASH and metabolomic networks from GNPS (Global Natural Products Social Molecular Networking) to form multi-layered knowledge graphs for AI reasoning [1, 2].

CONCLUSION

Applying artificial intelligence to natural product chemistry represents one of the most exciting edges of contemporary pharmaceutical discovery. But as demonstrated throughout this review, the field bottleneck has shifted from algorithms to data quality and standardization. By overcoming stereochemical ambiguity, embracing robust string notations like SELFIES, consolidating databases under FAIR principles, and prescribing comprehensive phytochemical metadata, the global scientific community can bridge the data divide. The standardization of ‘Nature’s Pharmacy’ will enable next-generation AI workflows to unlock novel therapeutics for complex human disease with unprecedented accuracy and speed.

REFERENCES

1. Geetha, J., Ranganathan, N., Gulothungan, G., & Chopra, H. (2026). Integrating Artificial Intelligence and Machine Learning in Natural Product Discovery: From Omics Data to Drug Design. Natural Resources & Health, https://doi.org/10.53365/nrfhh/217344
2. Paerhati, Y., Aikebaier, A., Dilimulati, D., Baishan, A., Yusufujiang, N., Qiu, X., Wusiman, Y., & Zhou, W. (2026). Rethinking Nature’s Pharmacy: AI Era and Natural Product Drug Discovery. Pharmaceuticals, 19(2), 301. https://doi.org/10.3390/ph19220301
3. Tay, D. W. P., Yeo, N. Z. X., Adaikkappan, K., Lim, Y. H., & Ang, S. J. (2023). 67 million natural product-like compound database generated via molecular language processing. Scientific Data, 10, 220. https://doi.org/10.1038/s41597-023-02207-x
4. Santen, J. A. V., Jacob, G., Singh, A., Aniebok, V., Balunas, M. J., Bunsko, D., et al. (2019). The Natural Products Atlas: An Open Access Knowledge Base for Microbial Natural Products Discovery. ACS Central Science, 5(11), 1824–1833. https://doi.org/10.1021/acscentsci.9b00806
5. Gallo, K., Kemmler, E., Goede, A., Becker, F., Dunkel, M., Preissner, R., & Banerjee, P. (2022). SuperNatural 3.0—a database of natural products and natural product-based derivatives. Nucleic Acids Research, 50(D1), D654–D660. https://doi.org/10.1093/nar/gkac1088